Docon Technologies Private Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Docon Technologies Private Limited, the promoter of Thyrocare Technologies Limited, has submitted its annual disclosure under SEBI Takeover Code Regulation 31(4). The promoter group holds 60.93% stake in Thyrocare. During FY 2025-26, the promoter released its entire pledge on September 16, 2025 (3,76,56,092 shares), bringing encumbrance to zero. Subsequently, a fresh pledge was created on September 17, 2025 on 3,23,23,232 shares (60.99%), and additional pledge on December 2, 2025 bringing total encumbered shares to 9,69,69,696 (60.93%). This increase was due to a 2:1 bonus share allotment on December 1, 2025, requiring fresh encumbrance on newly allotted shares. No additional encumbrances were made beyond those already disclosed.
The promoter maintaining 60.93% stake with encumbrance indicates continued control but with shares pledged as security. The pledge release and recreation shows active management of share-backed financing. Overall promoter holding remains strong above 60%, which is positive for control but the pledged portion may be a watch point for investors.